{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T22:42:44Z","timestamp":1777761764480,"version":"3.51.4"},"reference-count":32,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The presence of comorbidities in both the pre- and post-diagnostic periods is a critical consideration in the diagnosis and management of patients with cancer. This study aimed to investigate the prevalence and burden of pulmonary and extrapulmonary comorbidities in patients diagnosed with lung cancer (LC) and malignant pleural mesothelioma (MPM). Materials and Methods: The data were obtained from official patient records of the Turkish Ministry of Health. Patients diagnosed with either lung cancer (LC) or malignant pleural mesothelioma (MPM) between 2015 and 2018 were included in the study. Comorbidities were classified as pulmonary or extrapulmonary. Results: A total of 74,835 patients with LC and 1678 patients with MPM were included. The burden of comorbid conditions increased significantly in the post-diagnostic period in both males and females across both cancer types. When the two cancer groups were compared with respect to diagnostic periods, comorbidities such as hypertension (HT), phlebitis\/venous thrombosis\/thrombophlebitis, pulmonary embolism, pneumothorax, and pleural effusion were significantly more prevalent in the MPM group (p &lt; 0.05). Compared with the pre-diagnostic period, the comorbidity risk in LC was highest for pulmonary embolism, ARF, and pneumonia in the post-diagnostic period, whereas renal failure was the most frequent comorbidity in the MPM group (p &lt; 0.001 and p = 0.024). When comparing changes in comorbidity burden between sexes in the lung cancer group, male patients had higher frequencies of pulmonary embolism, pneumonia, pneumothorax, and coronary artery disease than females. In contrast, in the female lung cancer group, the prevalence of chronic renal failure was higher than in males (OR = 2.14 vs. 2.00), whereas acute renal failure was more prominent in the male patient group (OR = 2.64 vs. 1.94). In gender-based comparison of comorbid conditions among patients with MPM, the risk of renal failure was higher in females than in males (CRF and ARF respectively: OR = 2.63 vs. 2.16 and OR = 6.80 vs. 5.44). Additionally, increased rates of COPD were observed in male patients within this group (OR = 1.93 vs. 1.81). Conclusions: Patients with LC and MPM are burdened not only by their primary malignancies but also by a wide spectrum of comorbidities, particularly in the post-diagnostic period. Comprehensive knowledge of comorbid conditions is essential for clinicians to guide clinical decision-making, anticipate disease progression, and optimize treatment strategies, thereby informing national healthcare policies. Future studies incorporating matched control groups or longitudinal designs with standardized surveillance protocols may help conduct better research.<\/jats:p>","DOI":"10.3390\/medicina62050845","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:32:22Z","timestamp":1777469542000},"page":"845","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comorbidity Burden in Lung Cancer and Malignant Pleural Mesothelioma: Nationwide Database Results of Turkey"],"prefix":"10.3390","volume":"62","author":[{"given":"\u00c7i\u011fdem","family":"\u00d6zdilekcan","sequence":"first","affiliation":[{"name":"Department of Pulmonology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, 06200 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarkan","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital, 06200 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1503-7343","authenticated-orcid":false,"given":"Mustafa Hamidullah","family":"T\u00fcrkkan\u0131","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Faculty of Medicine, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University, Ankara City Hospital, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Ata","sequence":"additional","affiliation":[{"name":"Department of Strategy, Ministry of Health, 06100 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1449-7874","authenticated-orcid":false,"given":"Mesut","family":"Akyol","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Medicine, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mevl\u00fct","family":"Karata\u015f","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Ankara Occupational and Environmental Diseases Hospital, 06280 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6072-8587","authenticated-orcid":false,"given":"Asl\u0131han G\u00fcr\u00fcn","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Faculty of Medicine, Ankara University, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-2454","authenticated-orcid":false,"given":"Ayd\u0131n","family":"Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, University of Health Sciences, Ankara Atat\u00fcrk Sanatorium Education and Research Hospital, 06010 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ak\u0131n","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Faculty of Medicine, Ankara University, 06800 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-6198","authenticated-orcid":false,"given":"\u015euayip","family":"Birinci","sequence":"additional","affiliation":[{"name":"Republic of Turkey, Ministry of Health, 06100 Ankara, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"5","article-title":"The first Surgeon General\u2019s report on smoking and health: The 50th anniversary","volume":"64","author":"Brawley","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jtho.2022.06.001","article-title":"Lung Cancer in Turkey","volume":"17","author":"Yumuk","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.lungcan.2004.04.009","article-title":"Malignant pleural mesothelioma in Turkey, 2000\u20132002","volume":"45","author":"Emri","year":"2004","journal-title":"Lung Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"106527","DOI":"10.1016\/j.rmed.2021.106527","article-title":"Mesothelioma in immigrants from Turkey: Genes have a minor role","volume":"186","author":"Metintas","year":"2021","journal-title":"Respir. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2486\/indhealth.45.379","article-title":"Malignant mesothelioma: Global incidence and relationship with asbestos","volume":"45","author":"Bianchi","year":"2007","journal-title":"Ind. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/ejcts\/ezw215","article-title":"Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma","volume":"50","author":"Infante","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0021-9681(70)90054-8","article-title":"The pre-therapeutic classif\u0131cation of co-morbidity in chronic disease","volume":"23","author":"Feinstein","year":"1970","journal-title":"J. Chronic Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1370\/afm.983","article-title":"Defining comorbidity: Implications for understanding health and health services","volume":"7","author":"Valderas","year":"2009","journal-title":"Ann. Fam. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/bjc.2015.355","article-title":"The impact of patient comorbidity on cancer stage at diagnosis","volume":"113","author":"Gurney","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"ref_12","first-page":"337","article-title":"The impact of comorbidity on cancer and its treatment","volume":"66","author":"Sarfati","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/pubmed\/fdx072","article-title":"Do comorbidities influence help-seeking for cancer alarm symptoms? A population-based survey in England","volume":"40","author":"Salika","year":"2018","journal-title":"J. Public Health"},{"key":"ref_14","first-page":"186","article-title":"Comorbidities in lung cancer","volume":"84","author":"Dutkowska","year":"2016","journal-title":"Pneumonol. Alergol. Pol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ejca.2007.06.008","article-title":"Comorbidity in older surgical cancer patients: Influence on patient care and outcome","volume":"43","author":"Maas","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1","article-title":"Cancer and comorbidity: Redefining chronic diseases","volume":"88","author":"Ogle","year":"2000","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.21037\/tlcr-2025-480","article-title":"Comorbidity of lung cancer and chronic obstructive pulmonary disease: Correlation and optimization of treatment strategies","volume":"14","author":"Jiang","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1158\/1055-9965.EPI-15-0036","article-title":"Comorbidity and Survival in Lung Cancer Patients","volume":"24","author":"Islam","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mayocp.2015.09.009","article-title":"Prevalence of Preexisting Cardiovascular Disease in Patients with Different Types of Cancer: The Unmet Need for Onco-Cardiology","volume":"91","author":"Oliveira","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1007\/s12672-025-03323-3","article-title":"Comorbidity of hypertension and lung cancer: Interplay of genetics and environment","volume":"16","author":"Zeng","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/ijc.22532","article-title":"Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis","volume":"120","author":"Houterman","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5761\/atcs.ra.19-00170","article-title":"The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis","volume":"26","author":"Bi","year":"2020","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1252897","DOI":"10.1155\/2018\/1252897","article-title":"Effect of Comorbidity on Lung Cancer Diagnosis Timing and Mortality: A Nationwide Population-Based Cohort Study in Taiwan","volume":"2018","author":"Dima","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.athoracsur.2007.11.064","article-title":"Rate of thromboembolic events in mesothelioma","volume":"85","author":"Nguyen","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jtcvs.2019.12.115","article-title":"Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma","volume":"160","author":"Fox","year":"2020","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: Burden, mechanisms, and management","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/1076029614564861","article-title":"Thromboembolic Events in Malignant Pleural Mesothelioma","volume":"22","author":"Koksal","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/cam4.1378","article-title":"Determinants of malignant pleural mesothelioma survival and burden of disease in France: A national cohort analysis","volume":"7","author":"Chouaid","year":"2018","journal-title":"Cancer Med."},{"key":"ref_29","first-page":"e13171","article-title":"Comorbidities and relevant outcomes, commonly associated with cancer, of patients newly diagnosed with advanced non-small-cell lung cancer in Sweden","volume":"29","author":"Linden","year":"2020","journal-title":"Eur. J. Cancer Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"115303","DOI":"10.1016\/j.ejca.2025.115303","article-title":"Four decades of lung cancer: Trends in comorbidities and causes of death in a nationwide Danish cohort","volume":"218","author":"Borg","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e000796","DOI":"10.1136\/esmoopen-2020-000796","article-title":"Gender-specific aspects of epidemiology, molecular genetics and outcome: Lung cancer","volume":"5","author":"Mederos","year":"2020","journal-title":"ESMO Open."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/j.cllc.2020.05.021","article-title":"Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma","volume":"21","author":"Barsky","year":"2020","journal-title":"Clin. Lung Cancer"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/845\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:22:41Z","timestamp":1777472561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050845"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050845","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}